FDA Inspection 983887 — Midwest Transplant Network

Midwest Transplant Network — FEI 3001238375

The FDA completed an inspection of Midwest Transplant Network on August 25, 2016 in Westwood, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 25, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Westwood, KS (United States)